IPAD-DB ID | D01381 |
Name | Molsidomine |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 9 H 1 4 N 4 O 4 |
Molecular Weight | 242.23 g/mol |
IUPAC Name | (1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate |
InChI | InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3 |
InChIKey | XLFWDASMENKTKL-UHFFFAOYSA-N |
Canonical SMILES | CCOC(=NC1=C[N+](=NO1)N2CCOCC2)[O-] |
PubChem CID | 5353788 |
DrugBank Accession Number | DB09282 |
CAS Registry Number | 25717-80-0 |
Molecular Weight(Computed by SwissADME) | 242.23 |
Hac(Computed by SwissADME) | 17 |
Volume(Computed by ADMETlab 2.0) | 218.346 |
Density(Computed by ADMETlab 2.0) | 1.109 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 8 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 12 |
Flexibility(Computed by ADMETlab 2.0) | 0.333 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | 0.105 |
LogD(Computed by ADMETlab 2.0) | 0.892 |
logP(Computed by ADMETlab 2.0) | -0.204 |
TPSA(Computed by SwissADME) | 87.03 |
Hbond Acceptor(Computed by SwissADME) | 6 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 4 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.7 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |